1. New Zealand Diabetes Care Devices Market Outlook to 2017-
Glucose Monitoring and Insulin Delivery
Report Details:
Published:December 2011
No. of Pages: 95
Price: Single User License – US$2500
Corporate User License – US$7500
Report Summary
GlobalData’s new report, New Zealand Diabetes Care Devices Market Outlook to 2017- Glucose
Monitoring and Insulin Delivery provides key market data on the New Zealand Diabetes Care
Devices market. The report provides value (USD million), volume (units) and average price (USD)
data for each segment and sub-segment within two market categories – Glucose Monitoring and
Insulin Delivery. The report also provides company shares and distribution shares data for each of
the aforementioned market categories. The report is supplemented with global corporate-level
profiles of the key market participants with information on company financials and pipeline
products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
• Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2003 to 2010,
forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the New Zealand Diabetes
Care Devicesmarket.
• Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Abbott Laboratories,
Medtronic, Inc., Bayer HealthCare AG, Novo Nordisk A/S and others.
Reasons to buy
• Develop business strategies by identifying the key market categories and segments poised for
strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the New Zealand Diabetes
Care Devices competitive landscape.

2. • Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/144215-new-zealand-diabetes-care-devices-market-outlook-to-2017-
glucose-monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
3 Diabetes Care Devices In New Zealand 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, 2003-2017 10
3.3 Diabetes Care Devices Market, New Zealand, Revenue Mix ($m), 2010 11
3.4 Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2010 12
3.5 Diabetes Care Devices, New Zealand, Category Volume (Units), 2003-2017 19
3.6 Diabetes Care Devices, New Zealand, Company share (2009-2010) 24
4 Glucose Monitoring In New Zealand 26
4.1 Glucose Monitoring, Market Segmentation 26
4.2 Glucose Monitoring Market, New Zealand, Revenue Mix ($m), 2010 27
4.3 Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2010 28
4.4 Glucose Monitoring Overall Revenue (2003-2017) 29
4.4.1 Blood Glucose Meters Revenue (2003-2017) 33
4.5 Glucose Monitoring Overall Volume (2003-2017) 37
4.5.1 Blood Glucose Meters Volume (2003-2017) 41
4.6 Glucose Monitoring Average Price (2003-2017) 45
4.7 Glucose Monitoring Distribution Share (2009-2010) 46
4.8 Glucose Monitoring, New Zealand, Company share (2009-2010) 47
5 Insulin Delivery In New Zealand 49
5.1 Insulin Delivery, Market Segmentation 49
5.2 Insulin Delivery Market, New Zealand, Revenue Mix ($m), 2010 50

3. 5.3 Insulin Delivery Market, New Zealand, Segment Contribution (%), 2010 51
5.4 Insulin Delivery Overall Revenue (2003-2017) 52
5.4.1 Insulin Pens Revenue (2003-2017) 56
5.4.2 Insulin Pumps Revenue (2003-2017) 60
5.5 Insulin Delivery Overall Volume (2003-2017) 62
5.5.1 Insulin Pens Volume (2003-2017) 66
5.5.2 Insulin Pumps Volume (2003-2017) 70
5.6 Insulin Delivery Average Price (2003-2017) 72
5.7 Insulin Delivery Distribution Share (2009-2010) 73
5.8 Insulin Delivery, New Zealand, Company share (2009-2010) 74
6 Overview of Key Companies in New Zealand Diabetes Care Devices Market 76
6.1 F. Hoffmann-La Roche Ltd. 76
6.1.1 Company Overview 76
6.1.2 Share in the New Zealand Diabetes Care Devices Market 76
6.2 LifeScan, Inc. 77
6.2.1 Company Overview 77
6.2.2 Share in the New Zealand Diabetes Care Devices Market 77
6.3 Abbott Laboratories 78
6.3.1 Company Overview 78
6.3.2 Share in the New Zealand Diabetes Care Devices Market 78
6.4 Medtronic, Inc. 79
6.4.1 Company Overview 79
6.4.2 Share in the New Zealand Diabetes Care Devices Market 79
6.5 Bayer HealthCare AG 80
6.5.1 Company Overview 80
6.5.2 Share in the New Zealand Diabetes Care Devices Market 80
6.6 Novo Nordisk A/S 81
6.6.1 Company Overview 81
6.6.2 Share in the New Zealand Diabetes Care Devices Market 81
6.7 ARKRAY, Inc. 82
6.7.1 Company Overview 82
6.8 Sanofi 82
6.8.1 Company Overview 82
6.9 Eli Lilly and Company 82
6.9.1 Company Overview 82
6.10 Terumo Corporation 83
6.10.1 Company Overview 83
6.11 Animas Corporation 83
6.11.1 Company Overview 83
6.12 NIPRO CORPORATION 83

4. 6.12.1 Company Overview 83
6.13 Becton, Dickinson and Company 84
6.13.1 Company Overview 84
7 Diabetes Care Devices Market Pipeline Products 85
8 Appendix 88
8.1 Definitions of Markets Covered in the Report 89
8.1.1 Diabetes Care Devices 89
8.2 Research Methodology 92
8.3 Secondary Research 92
8.4 Primary Research 93
8.5 Models 93
8.6 Forecasts 94
8.7 Expert Panels 94
8.8 GlobalData Consulting 94
8.9 Currency Conversion 95
8.10 Contact Us 95
8.11 Disclaimer 95
List of Tables
Table 1:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, 2003-2017 10
Table 2:Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2010 12
Table 3:Diabetes Care Devices, New Zealand, Cross-Segment Analysis, 2003-2017 14
Table 4:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, Historic, 2003-
2010 16
Table 5:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, Forecast,
2010-2017 18
Table 6:Diabetes Care Devices, New Zealand, Category Volume (Units), 2003-2017 19
Table 7:Diabetes Care Devices, New Zealand, Category Volume (Units), Historic, 2003-2010 21
Table 8:Diabetes Care Devices, New Zealand, Category Volume (Units), Forecast, 2010-2017 23
Table 9:Diabetes Care Devices, New Zealand, Company share by Revenue ($m), USD Actual,
2009-2010 25
Table 10:Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2010 28
Table 11:Glucose Monitoring, New Zealand, Revenue ($m), USD Actual by Segment, Historic,
2003-2010 30
Table 12:Glucose Monitoring, New Zealand, Revenue ($m), USD Actual by Segment, Forecast,
2010-2017 32
Table 13:Blood Glucose Meters, New Zealand, Revenue ($m), USD Actual by Sub-Segment,
Historic, 2003-2010 34

5. Table 14:Blood Glucose Meters, New Zealand, Revenue ($m), USD Actual by Sub-Segment,
Forecast, 2010-2017 36
Table 15:Glucose Monitoring, New Zealand, Volume (Units) by Segment, Historic, 2003-2010 38
Table 16:Glucose Monitoring, New Zealand, Volume (Units) by Segment, Forecast, 2010-2017 40
Table 17:Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Historic, 2003-
2010 42
Table 18:Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2010-
2017 44
Table 19:Glucose Monitoring, New Zealand, Average Price ($), Historic, 2003-2010 45
Table 20:Glucose Monitoring, New Zealand, Average Price ($), Forecast, 2010-2017 45
Table 21:Glucose Monitoring, New Zealand, Distribution Share by Revenue ($m), USD Actual,
2009-2010 46
Table 22:Glucose Monitoring, New Zealand, Company share by Revenue ($m), USD Actual 2009-
2010 48
Table 23:Insulin Delivery Market, New Zealand, Segment Contribution (%), 2010 51
Table 24:Insulin Delivery, New Zealand, Revenue ($m), USD Actual by Segment, Historic, 2003-
2010 53
Table 25:Insulin Delivery, New Zealand, Revenue ($m), USD Actual by Segment, Forecast, 2010-
2017 55
Table 26:Insulin Pens, New Zealand, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-
2010 57
Table 27:Insulin Pens, New Zealand, Revenue ($m), USD Actual by Sub-Segment, Forecast,
2010-2017 59
Table 28:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Revenue ($m), USD Actual,
Historic, 2003-2010 60
Table 29:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Revenue ($m), USD Actual,
Forecast, 2010-2017 61
Table 30:Insulin Delivery, New Zealand, Volume (Units) by Segment, Historic, 2003-2010 63
Table 31:Insulin Delivery, New Zealand, Volume (Units) by Segment, Forecast, 2010-2017 65
Table 32:Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Table 33:Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Table 34:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Volume (Units), Historic, 2003-
2010 70
Table 35:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Volume (Units), Forecast,
2010-2017 71
Table 36:Insulin Delivery, New Zealand, Average Price ($), Historic, 2003-2010 72
Table 37:Insulin Delivery, New Zealand, Average Price ($), Forecast, 2010-2017 72
Table 38:Insulin Delivery, New Zealand, Distribution Share by Revenue ($m), USD Actual, 2009-
2010 73
Table 39:Insulin Delivery, New Zealand, Company share by Revenue ($m), USD Actual 2009-
2010 75

6. Table 40:Diabetes Care Devices Market Pipeline Products 85
Table 41: USD to Local Currency, New Zealand, Average Actual Rate 2003-2010 95
List of Figures
Figure 1:Diabetes Care Devices, Market Segmentation 9
Figure 2:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, 2003-2017 10
Figure 3:Diabetes Care Devices Market, New Zealand, Revenue Mix ($m), 2010 11
Figure 4:Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2010 12
Figure 5:Diabetes Care Devices, New Zealand, Cross-Segment Analysis, 2003-2017 13
Figure 6:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, Historic,
2003-2010 15
Figure 7:Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Actual, Forecast,
2010-2017 17
Figure 8:Diabetes Care Devices, New Zealand, Category Volume (Units), 2003-2017 19
Figure 9:Diabetes Care Devices, New Zealand, Category Volume (Units), Historic, 2003-2010 20
Figure 10:Diabetes Care Devices, New Zealand, Category Volume (Units), Forecast, 2010-2017
22
Figure 11:Diabetes Care Devices, New Zealand, Company share (%), 2010 24
Figure 12:Glucose Monitoring, Market Segmentation 26
Figure 13:Glucose Monitoring Market, New Zealand, Revenue Mix ($m), 2010 27
Figure 14:Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2010 28
Figure 15:Glucose Monitoring, New Zealand, Revenue ($m), USD Actual by Segment, Historic,
2003-2010 29
Figure 16:Glucose Monitoring, New Zealand, Revenue ($m), USD Actual by Segment, Forecast,
2010-2017 31
Figure 17:Blood Glucose Meters, New Zealand, Revenue ($m), USD Actual by Sub-Segment,
Historic, 2003-2010 33
Figure 18:Blood Glucose Meters, New Zealand, Revenue ($m), USD Actual by Sub-Segment,
Forecast, 2010-2017 35
Figure 19:Glucose Monitoring, New Zealand, Volume (Units) by Segment, Historic, 2003-2010 37
Figure 20:Glucose Monitoring, New Zealand, Volume (Units) by Segment, Forecast, 2010-2017 39
Figure 21:Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Historic, 2003-
2010 41
Figure 22:Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2010-
2017 43
Figure 23:Glucose Monitoring, New Zealand, Company share (%), 2010 47
Figure 24:Insulin Delivery, Market Segmentation 49
Figure 25:Insulin Delivery Market, New Zealand, Revenue Mix ($m), 2010 50
Figure 26:Insulin Delivery Market, New Zealand, Segment Contribution (%), 2010 51
Figure 27:Insulin Delivery, New Zealand, Revenue ($m), USD Actual by Segment, Historic, 2003-

7. 2010 52
Figure 28:Insulin Delivery, New Zealand, Revenue ($m), USD Actual by Segment, Forecast, 2010-
2017 54
Figure 29:Insulin Pens, New Zealand, Revenue ($m), USD Actual by Sub-Segment, Historic,
2003-2010 56
Figure 30:Insulin Pens, New Zealand, Revenue ($m), USD Actual by Sub-Segment, Forecast,
2010-2017 58
Figure 31:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Revenue ($m), USD Actual,
Historic, 2003-2010 60
Figure 32:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Revenue ($m), USD Actual,
Forecast, 2010-2017 61
Figure 33:Insulin Delivery, New Zealand, Volume (Units) by Segment, Historic, 2003-2010 62
Figure 34:Insulin Delivery, New Zealand, Volume (Units) by Segment, Forecast, 2010-2017 64
Figure 35:Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Figure 36:Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 37:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Volume (Units), Historic, 2003-
2010 70
Figure 38:Insulin Pumps (Traditional Insulin Pumps), New Zealand, Volume (Units), Forecast,
2010-2017 71
Figure 39:Insulin Delivery, New Zealand, Company share (%), 2010 74
Figure 40:F. Hoffmann-La Roche Ltd., Company Share (%),New Zealand Diabetes Care Devices
Market, 2010 76
Figure 41:LifeScan, Inc., Company Share (%),New Zealand Diabetes Care Devices Market, 2010
77
Figure 42:Abbott Laboratories, Company Share (%),New Zealand Diabetes Care Devices Market,
2010 78
Figure 43:Medtronic, Inc., Company Share (%),New Zealand Diabetes Care Devices Market, 2010
79
Figure 44:Bayer HealthCare AG, Company Share (%),New Zealand Diabetes Care Devices
Market, 2010 80
Figure 45:Novo Nordisk A/S., Company Share (%),New Zealand Diabetes Care Devices Market,
2010 81
Contact: sales@reportsandreports.com for more information.